The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
Swerdlow, S. H. (2017) · Medical Entomology and Zoology · Cited by 12,933
World Health Organization Classification of Tumours
Fletcher, C., van den Berg, A., & Molenaar, I. (2002) · Cited by 7,079
International System for Human Cytogenetic Nomenclature
National Cancer Institute (2020) · Definitions · doi:10.32388/78qroa · Cited by 6,840
Hossfeld, D. K. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf146 · Cited by 4,625
International scoring system for evaluating prognosis in myelodysplastic syndromes
Greenberg, P., Cox, C., LeBeau, M. M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., et al. (1997) · Blood · doi:10.1182/blood.v89.6.2079 · Cited by 4,427
Self-citationProposals for the classification of the myelodysplastic syndromes
Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A. G., Gralnick, H. R., & Sultan, C. (1982) · British Journal of Haematology · doi:10.1111/j.1365-2141.1982.tb08475.x · Cited by 3,627
Self-citationKolb, H., Schattenberg, A., Goldman, J., Hertenstein, B., Jacobsen, N., Arcese, W., Ljungman, P., Ferrant, A., Verdonck, L., & Niederwieser, D. (1995) · Blood · doi:10.1182/blood.v86.5.2041.bloodjournal8652041 · Cited by 1,934
Self-citationSilverman, L. R., Demakos, E. P., Peterson, B. L., Kornblith, A. B., Holland, J. C., Odchimar-Reissig, R., Stone, R. M., Nelson, D., Powell, B. L., DeCastro, C. M., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.04.117 · Cited by 1,825
Cheson, B. D. (2006) · Blood · doi:10.1182/blood-2005-10-4149 · Cited by 1,580
Kantarjian, H., Issa, J. J., Rosenfeld, C. S., Bennett, J. M., Albitar, M., DiPersio, J., Klimek, V., Slack, J., de Castro, C., Ravandi, F., et al. (2006) · Cancer · doi:10.1002/cncr.21792 · Cited by 1,530
Self-citationLenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion
List, A., Dewald, G., Bennett, J., Giagounidis, A., Raza, A., Feldman, E., Powell, B., Greenberg, P., Thomas, D., Stone, R., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061292 · Cited by 1,319
Self-citationMalcovati, L., Porta, M. G. D., Pascutto, C., Invernizzi, R., Boni, M., Travaglino, E., Passamonti, F., Arcaini, L., Maffioli, M., Bernasconi, P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.7038 · Cited by 865
Kantarjian, H., Oki, Y., Garcia-Manero, G., Huang, X., O'Brien, S., Cortes, J., Faderl, S., Bueso-Ramos, C., Ravandi, F., Estrov, Z., et al. (2007) · Blood · doi:10.1182/blood-2006-05-021162 · Cited by 685
Cheson, B. D., Bennett, J. M., Kantarjian, H. M., Pinto, A., Schiffer, C. A., Nimer, S. D., Löwenberg, B., Beran, M., de Witte, T. M., Stone, R. M., et al. (2000) · PubMed · Cited by 666
Self-citationWells, D. A., Benesch, M., Loken, M. R., Vallejo, C., Myerson, D., Leisenring, W. M., & Deeg, H. J. (2003) · Blood · doi:10.1182/blood-2002-09-2768 · Cited by 358
Self-citationHellström-Lindberg, E., Ahlgren, T., Beguin, Y., Carlsson, M., Carneskog, J., Dahl, I. M., Dybedal, I., Grimfors, G., Kanter-Lewensohn, L., Linder, O., et al. (1998) · Blood · doi:10.1182/blood.v92.1.68.413k23_68_75 · Cited by 304
Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes
Bowen, D., Culligan, D., Jowitt, S., Kelsey, S., Mufti, G., Oscier, D., Parker, J., & of the UK MDS Guidelines Group (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.03907.x · Cited by 298
Saunthararajah, Y., Nakamura, R., Nam, J.-M., Robyn, J., Loberiza, F., Maciejewski, J. P., Simonis, T., Molldrem, J., Young, N. S., & Barrett, A. J. (2002) · Blood · doi:10.1182/blood.v100.5.1570.h81702001570_1570_1574 · Cited by 273
De Witte, T., Hermans, J., Vossen, J., Bacigalupo, A., Meloni, G., Jacobsen, N., Ruutu, T., Ljungman, P., Gratwohl, A., Runde, V., et al. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02200.x · Cited by 251
The Myelodysplastic Syndromes: Diagnosis and Treatment
Steensma, D. P., & Bennett, J. M. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.1.104 · Cited by 245
Self-citationCharacterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow
Hofmann, W.-K., de Vos, S., Komor, M., Hoelzer, D., Wachsman, W., & Koeffler, H. P. (2002) · Blood · doi:10.1182/blood.v100.10.3553 · Cited by 236
(1981) · Cytogenetic and Genome Research · doi:10.1159/000131621 · Cited by 220
Szpurka, H., Tiu, R., Murugesan, G., Aboudola, S., Hsi, E. D., Theil, K. S., Sekeres, M. A., & Maciejewski, J. P. (2006) · Blood · doi:10.1182/blood-2006-02-005751 · Cited by 209
Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF
Jädersten, M., Montgomery, S. M., Dybedal, I., Porwit-MacDonald, A., & Hellström-Lindberg, E. (2005) · Blood · doi:10.1182/blood-2004-10-3872 · Cited by 205
Tricot, G., Wolf‐Peeters, C. D., Vlietinck, R., & Verwilghen, R. L. (1984) · British Journal of Haematology · doi:10.1111/j.1365-2141.1984.tb06079.x · Cited by 202
Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome
Ogata, K. (2002) · Blood · doi:10.1182/blood-2002-01-0222 · Cited by 186
Self-citationOgata, K., Kishikawa, Y., Satoh, C., Tamura, H., Dan, K., & Hayashi, A. (2006) · Blood · doi:10.1182/blood-2005-12-4916 · Cited by 166
Self-citationHorny, H.-P., Sotlar, K., Sperr, W. R., & Valent, P. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.014860 · Cited by 163
Self-citationGerming, U., Hildebrandt, B., Pfeilstöcker, M., Nösslinger, T., Valent, P., Fonatsch, C., Lübbert, M., Haase, D., Steidl, C., Krieger, O., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2403963 · Cited by 162
Self-citationChromosome and Molecular Abnormalities in Myelodysplastic Syndromes
Fenaux, P. (2001) · International Journal of Hematology · doi:10.1007/bf02994004 · Cited by 114
Darbepoetin alpha for the treatment of anaemia in low‐intermediate risk myelodysplastic syndromes
Musto, P., Lanza, F., Balleari, E., Grossi, A., Falcone, A. P., Sanpaolo, G., Bodenizza, C., Scalzulli, P. R., Sala, A. L., Campioni, D., et al. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05288.x · Cited by 95
Ingram, W. A., Lea, N. C., Cervera, J., Germing, U., Fenaux, P., Cassinat, B., Kiladjian, J., Várkonyi, J., Antunović, P., Westwood, N., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404215 · Cited by 95
Self-citationGene expression profiling in the myelodysplastic syndromes using cDNA microarray technology
Pellagatti, A., Esoof, N., Watkins, F., Langford, C., Vetrie, D. L. P., Campbell, L. J., Fidler, C., Cavenagh, J. D., Eagleton, H., Gordon, P., et al. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04958.x · Cited by 88
Serum Tryptase Measurements in Patients with Myelodysplastic Syndromes
Sperr, W. R., Stehberger, B., Wimazal, F., Baghestanian, M., Schwartz, L. B., Kundi, M., Semper, H., Jordan, J.-H., Chott, A., Drach, J., et al. (2002) · Leukemia & Lymphoma · doi:10.1080/10428190290021470 · Cited by 83
Self-citationMyelodysplastic Syndromes: Iron Overload Consequences and Current Chelating Therapies
Greenberg, P. L. (2006) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2006.0010 · Cited by 83
Self-citationCherry, A. M., Brockman, S. R., Paternoster, S. F., Hicks, G. A., Neuberg, D. S., Higgins, R. R., Bennett, J. M., Greenberg, P. L., Miller, K. B., Tallman, M. S., et al. (2003) · Leukemia Research · doi:10.1016/s0145-2126(03)00104-8 · Cited by 79
Self-citationThe myelodysplastic syndromes: Diagnosis, molecular biology and risk assessment
Bennett, J. M., & Komrokji, R. S. (2005) · Hematology · doi:10.1080/10245330512331390311 · Cited by 71
Self-citationA Comparative Review of Classification Systems in Myelodysplastic Syndromes (MDS)
Bennett, J. M. (2005) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.06.021 · Cited by 68
Self-citationBERNASCONI, P. P., Cavigliano, P. M., Boni, M., Calatroni, S., Klersy, C., Giardini, I., Rocca, B., Crosetto, N., Caresana, M., Lazzarino, M., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2403108 · Cited by 66
Rüter, B. H., Wijermans, P., & Lübbert, M. (2004) · International Journal of Hematology · doi:10.1532/ijh97.04094 · Cited by 63
Self-citationVerburgh, E. R., Achten, R., Maes, B., Hagemeijer, A., Boogaerts, M. A., Wolf‐Peeters, C. D., & Verhoef, G. E. G. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.182 · Cited by 61
Hofmann, W.-K., Heil, G., Zander, C., Wiebe, S., Ottmann, O. G., Bergmann, L., Hoeffken, K., Fischer, J. T., Knuth, A. K., Kolbe, K., et al. (2004) · Annals of Hematology · doi:10.1007/s00277-004-0889-0 · Cited by 57
Reference standards for bone marrow cellularity
Tüzüner, N., & Bennett, J. M. (1994) · Leukemia Research · doi:10.1016/0145-2126(94)90048-5 · Cited by 44
Self-citationPrognostic value of lactate dehydrogenase activity in myelodysplastic syndromes
Wimazal, F., Sperr, W. R., Kundi, M., Meidlinger, P., Fonatsch, C., Jordan, J.-H., Thalhammer-Scherrer, R., Schwarzinger, I., Geissler, K. H., Lechner, K., et al. (2001) · Leukemia Research · doi:10.1016/s0145-2126(00)00140-5 · Cited by 43
Self-citationHorny, H. ‐., Greschniok, A., Jordan, J.-H., Menke, D. M., & Valent, P. (2003) · Journal of Clinical Pathology · doi:10.1136/jcp.56.2.103 · Cited by 38
Self-citationOptimization of Transplant Regimens for Patients with Myelodysplastic Syndrome (MDS)
Deeg, H. J. (2005) · Hematology · doi:10.1182/asheducation-2005.1.167 · Cited by 31
Pathogenesis, classification, and treatment of myelodysplastic syndromes (MDS)
Valent, P., Wimazal, F., Schwarzinger, I., Sperr, W. R., & Geissler, K. H. (2003) · Wiener klinische Wochenschrift · doi:10.1007/bf03041035 · Cited by 4
Self-citation
Cited by
Fenaux, P., Mufti, G. J., Hellstrom-Lindberg, E., Santini, V., Finelli, C., Giagounidis, A., Schoch, R., Gattermann, N., Sanz, G., List, A., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70003-8 · Cited by 2,663
Self-citationClonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
Steensma, D. P., Bejar, R., Jaiswal, S., Lindsley, R. C., Sekeres, M. A., Hasserjian, R. P., & Ebert, B. L. (2015) · Blood · doi:10.1182/blood-2015-03-631747 · Cited by 1,971
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Haase, D., Germing, U., Schanz, J., Pfeilstöcker, M., Nösslinger, T., Hildebrandt, B., Kundgen, A., Lübbert, M., Kunzmann, R., Giagounidis, A. A. N., et al. (2007) · Blood · doi:10.1182/blood-2007-03-082404 · Cited by 794
Self-citationSchanz, J., Tüchler, H., Solé, F., Mallo, M., Luño, E., Cervera, J., Granada, I., Hildebrandt, B., Slovak, M. L., Ohyashiki, K., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.6394 · Cited by 688
Self-citation
Metadata
- Authors
- Valent, P., Horny, H.-P., Bennett, J. M., Fonatsch, C., Germing, U., Greenberg, P., Haferlach, T., Haase, D., Kolb, H.-J., Krieger, O., Loken, M., van de Loosdrecht, A., Ogata, K., Orfao, A., Pfeilstöcker, M., Rüter, B., Sperr, W. R., Stauder, R., & Wells, D. A.
- Venue
- Leukemia Research
- Publisher
- Elsevier BV
- Published
- 2007-06
- Volume
- 31
- Issue
- 6
- Pages
- 727-736
- ISSN
- 0145-2126 (ISSN-L)
- OpenAlex
- W2061862949
- Cited by
- 513
- References
- 48
- FWCI
- 24.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.